Murphy Capital Management Inc. purchased a new position in Express Scripts Holding Co (NASDAQ:ESRX) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 2,400 shares of the company’s stock, valued at approximately $228,000.

Several other institutional investors have also recently added to or reduced their stakes in ESRX. Bank of Stockton increased its stake in Express Scripts by 5.2% in the third quarter. Bank of Stockton now owns 11,821 shares of the company’s stock valued at $1,123,000 after acquiring an additional 581 shares during the last quarter. Sumitomo Life Insurance Co. increased its stake in Express Scripts by 4.5% in the second quarter. Sumitomo Life Insurance Co. now owns 15,313 shares of the company’s stock valued at $1,182,000 after acquiring an additional 657 shares during the last quarter. Gibraltar Capital Management Inc. increased its stake in Express Scripts by 1.1% in the second quarter. Gibraltar Capital Management Inc. now owns 68,278 shares of the company’s stock valued at $5,272,000 after acquiring an additional 750 shares during the last quarter. Hancock Holding Co. increased its stake in Express Scripts by 3.4% in the first quarter. Hancock Holding Co. now owns 23,052 shares of the company’s stock valued at $1,592,000 after acquiring an additional 764 shares during the last quarter. Finally, Pinnacle Financial Partners Inc. increased its stake in Express Scripts by 9.9% in the second quarter. Pinnacle Financial Partners Inc. now owns 8,600 shares of the company’s stock valued at $663,000 after acquiring an additional 773 shares during the last quarter. 84.73% of the stock is currently owned by hedge funds and other institutional investors.

Shares of NASDAQ:ESRX opened at $94.29 on Friday. Express Scripts Holding Co has a 12-month low of $55.80 and a 12-month high of $97.22. The stock has a market cap of $53.41 billion, a PE ratio of 13.28, a P/E/G ratio of 1.20 and a beta of 1.01. The company has a current ratio of 0.71, a quick ratio of 0.59 and a debt-to-equity ratio of 0.69.

Express Scripts (NASDAQ:ESRX) last announced its quarterly earnings data on Wednesday, August 1st. The company reported $2.22 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.20 by $0.02. Express Scripts had a return on equity of 25.49% and a net margin of 4.65%. The firm had revenue of $25.64 billion for the quarter, compared to analysts’ expectations of $25.43 billion. During the same period last year, the firm earned $1.73 earnings per share. The company’s revenue for the quarter was up 1.2% compared to the same quarter last year. As a group, analysts anticipate that Express Scripts Holding Co will post 9.07 EPS for the current year.

ESRX has been the topic of a number of research analyst reports. BidaskClub raised Express Scripts from a “hold” rating to a “buy” rating in a research note on Tuesday, September 18th. ValuEngine raised Express Scripts from a “hold” rating to a “buy” rating in a research note on Monday, September 17th. Zacks Investment Research raised Express Scripts from a “strong sell” rating to a “hold” rating in a research note on Tuesday, June 26th. Credit Suisse Group cut Express Scripts from an “outperform” rating to a “neutral” rating and increased their target price for the company from $90.00 to $96.50 in a research note on Tuesday, September 18th. Finally, Robert W. Baird cut Express Scripts from an “outperform” rating to a “neutral” rating and set a $81.00 target price on the stock. in a research note on Friday, July 20th. Two equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $86.36.

In other news, insider Christine Houston sold 12,898 shares of the firm’s stock in a transaction dated Friday, August 10th. The stock was sold at an average price of $85.00, for a total transaction of $1,096,330.00. Following the transaction, the insider now directly owns 110,908 shares of the company’s stock, valued at $9,427,180. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 0.79% of the stock is currently owned by company insiders.

About Express Scripts

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.

Featured Story: Treasury Bonds

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Co (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.